Back to catalog
Tirzepatide
Dual GIP & GLP-1 Receptor Agonist Peptide
A novel dual agonist peptide that targets both GIP and GLP-1 receptors, studied for weight management, glucose control, and metabolic health.
Select size
$100.00 / 40 mg vial
Dual Agonist Mechanism
- Enhances insulin secretion dependent on glucose
- Suppresses glucagon secretion
- Slows gastric emptying
Weight Management Support
- Reduces appetite and food intake
- Increases feelings of fullness
- Supports reduction in body fat
Glycemic Control Support
- Improves insulin sensitivity
- Lowers fasting and postprandial glucose
- Enhances overall glucose control
Studied For
Significant Weight Loss Support
Appetite & Cravings Reduction
Improved Blood Sugar Control
Enhanced Insulin Sensitivity
Cardiometabolic Health Support
Lipid Profile Improvement
Research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.